Insights On Partnering

  1. Are You An Emerging Biotech? Things To Consider When Selecting A CRO 7/22/2024

    Better understand how smaller biotech companies should approach CRO selection and what they should consider before launching their clinical development program.

  2. Meeting Eye Exam Needs At The Point Of Need 3/11/2025

    Learn more about how mobile vision clinics supported the staff at trial sites as well as the patients through the COVID-19 pandemic and beyond.

  3. The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials 10/21/2025

    Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.

  4. How To Select The Right Bioanalysis CRO For Your Program 11/3/2025

    The right bioanalysis CRO accelerates progress, while the wrong one can derail outcomes. When every provider claims speed and credibility, how do you confidently choose the right partner?

  5. Global Vaccine Trials Case Study 5/22/2024

    Explore targeted strategies for tackling the complexities of international payments and providing comprehensive participant support in global vaccine trials.

  6. Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDC 12/6/2024

    Disconnected systems for eConsent and EDC create inefficiencies that burden clinical trial teams, but modern integrated platform solutions are streamlining operations.

  7. Study Analysis – Site Payment Automation 12/8/2025

    By removing administrative bottlenecks, see how automation improves cash flow for sites, reduces operational burden for sponsors, and supports smoother, more predictable trial execution.

  8. Accelerating Parkinson's Disease Clinical Research Through CHDR's Monocentre Recruitment Capabilities 1/14/2026

    Centralized PD trials reduce variability, accelerate enrolment, and enable genetic stratification for targeted therapies. This streamlined model delivers high-quality data and faster timelines, helping sponsors move confidently from early-phase research to late-stage development.

  9. Clinical Trials In The Age Of Cost Caps 4/14/2025

    On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.

  10. Using Technology To Reduce Monitoring Costs And Increase Quality 2/18/2025

    Join industry experts as they discuss how the true value of DDC lies not just in the cost of the technology itself but in the operational efficiencies it unlocks.